The market for Electrodermal Activity Detecting Devices Market is expected to reach USD$ XX in 2027.
The Electrodermal activity detecting devices market is set to project promising growth at a compounded annual growth rate (CAGR) of 8.7% during the forecast period from 2019 to 2027. Electrodermal activity detection, also known as galvanic skin response, employs sensors for measuring and detecting human stress and different emotional activities. The important parameters assessed by employing EDA devices are arousal detection, emotional cartography, relaxation biofeedback, etc.
Electrodermal activity detecting (EDA) wearable devices are being widely employed in psychiatric medical studies to understand various mental disorders and their early detection. Currently, psychological awareness is dominating the application segment for the electrodermal activity-detecting devices market. The rising prevalence of mental disorders and increasing demand for creating novel technology to measure sudomotor nerve activities drive the psychological arousal market growth. The rationale behind the development of this EDA technology is to create an excellent human-machine interface to understand different emotional states and provide optimum mental health management.
Under the influence of the sympathetic nervous system, the device measures the changes in skin conductivity by placing the electrodes at specific sites such as hand palms and feet soles, etc. Physiological arousal will garner tremendous attention owing to the increasing demand to understand risk perception associated with worker's safety and decision-making process and drastically reduce profession-associated trauma and accident cases
North America is clearly spearheading the regional segment for the electrodermal activity detecting devices market, representing a market share of 45%.
The major criterions related to its overwhelming market growth are the establishment of developed medical device industries manufacturing state-of-the-art medical gadgets and increasing public health awareness pertaining to electrodermal activity detecting wearable devices. Europe is placed in the second position holding a share of 30% owing to the strategic collaboration between medical device companies and academic research institutes to develop technology pertaining to electrodermal activity detecting devices.
European Medical Agency (EMA) has adopted a proactive role in granting early CE approval for medical devices used in medical diagnosis and mental monitoring activities. Asia Pacific currently holds a 15% market share and is set to register impressive market growth during the forecast period owing to developing healthcare infrastructure and lucrative market opportunities for medical device manufacturers to establish subsidiaries.
This research report presents the analysis of each segment from 2017 to 2027, considering 2018 as the base year for the research. Compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2019 to 2027.
Medical device manufacturers competing in the electrodermal activity detecting devices market are BrainSigns, Srl, Eisco Labs, iMotions, Movisens GmbH, Maxim Integrated, PLUX Wireless Biosignals S.A., Shimmer, and Vernier Software & Technology, LLC.
The market for Electrodermal Activity Detecting Devices Market is expected to reach USD$ XX in 2027.
The Electrodermal Activity Detecting Devices Market is expected to see significant CAGR growth over the coming years, at 8.7%.
The report is forecasted from 2019 -2027.
The base year of this report is 2018.
BrainSigns, Srl, Eisco Labs, iMotions, Movisens GmbH, Maxim Integrated, PLUX Wireless Biosignals S.A., Shimmer.are some of the major players in the global market.